Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (518) 518
cardiac & cardiovascular systems (488) 488
index medicus (472) 472
paclitaxel-eluting stents (370) 370
paclitaxel-eluting stent (341) 341
male (316) 316
female (293) 293
treatment outcome (269) 269
drug-eluting stents (256) 256
stents (255) 255
middle aged (245) 245
aged (239) 239
restenosis (237) 237
stent (192) 192
implantation (189) 189
percutaneous coronary intervention (172) 172
angioplasty (160) 160
time factors (159) 159
paclitaxel - administration & dosage (155) 155
thrombosis (138) 138
follow-up (123) 123
cardiovascular (120) 120
follow-up studies (118) 118
coronary angiography (117) 117
bare-metal stents (114) 114
prosthesis design (114) 114
trial (113) 113
balloon angioplasty (111) 111
risk factors (111) 111
coronary artery disease - therapy (109) 109
lesions (105) 105
peripheral vascular disease (100) 100
prospective studies (95) 95
outcomes (92) 92
cardiovascular agents - administration & dosage (89) 89
paclitaxel (89) 89
sirolimus - administration & dosage (88) 88
coronary-artery-disease (87) 87
revascularization (87) 87
artery-disease (85) 85
cardiology (83) 83
drug-eluting stent (82) 82
disease (81) 81
in-stent restenosis (81) 81
angioplasty, balloon, coronary - instrumentation (77) 77
sirolimus-eluting stent (76) 76
animals (75) 75
transluminal angioplasty (75) 75
angioplasty, balloon, coronary - adverse effects (74) 74
surgery (74) 74
retrospective studies (72) 72
analysis (70) 70
paclitaxel-eluting balloon (69) 69
kaplan-meier estimate (68) 68
registries (68) 68
coronary artery disease (67) 67
randomized controlled-trial (65) 65
randomized-trial (64) 64
coronary restenosis - prevention & control (62) 62
abridged index medicus (61) 61
coronary restenosis - etiology (61) 61
intravascular ultrasound (59) 59
superficial femoral-artery (59) 59
intervention (58) 58
care and treatment (56) 56
sirolimus (55) 55
aged, 80 and over (53) 53
drug-coated balloon (53) 53
optical coherence tomography (53) 53
medicine, general & internal (52) 52
coronary heart disease (51) 51
heart attacks (51) 51
coronary artery disease - mortality (49) 49
stenosis (49) 49
coated materials, biocompatible (48) 48
everolimus (48) 48
metaanalysis (48) 48
percutaneous coronary intervention - adverse effects (48) 48
stent thrombosis (47) 47
clinical-outcomes (46) 46
everolimus-eluting stent (46) 46
paclitaxel - therapeutic use (46) 46
cardiology and cardiovascular medicine (45) 45
drug-eluting stents - adverse effects (45) 45
mortality (45) 45
percutaneous coronary intervention - instrumentation (45) 45
coronary artery disease - diagnostic imaging (44) 44
coronary stenosis - therapy (44) 44
vascular patency (44) 44
medicine & public health (43) 43
angioplasty, balloon, coronary - methods (42) 42
bare-metal stent (42) 42
coronary vessels (42) 42
diabetes (42) 42
thrombosis - etiology (42) 42
myocardial infarction - etiology (41) 41
pharmacology & pharmacy (41) 41
angioplasty, balloon, coronary (40) 40
cardiac patients (40) 40
multicenter (40) 40
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (796) 796
Chinese (13) 13
Spanish (9) 9
French (7) 7
German (5) 5
Polish (5) 5
Japanese (2) 2
Portuguese (2) 2
Russian (2) 2
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry
by Werkum, J.W. van and Heestermans, A.A and Zomer, A.C and Kelder, J.C and Suttorp, M.J and Rensing, B.J and Koolen, J.J and Brueren, B.R and Dambrink, J.H and Hautvast, R.W and Verheugt, F.W.A and Berg, J.M. ten
Journal of the American College of Cardiology, ISSN 0735-1097, 2009, Volume 53, Issue 16, pp. 1399 - 1409
OBJECTIVES: This study sought to comprehensively identify predictors of stent thrombosis (ST). BACKGROUND: Given the devastating consequences of ST, efforts... 
clopidogrel | predictors | bare-metal stent | drug-eluting stent | stent thrombosis | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | PACLITAXEL-ELUTING STENTS | ANGIOPLASTY | IMPLANTATION | ERA | FREQUENCY | INTRAVASCULAR ULTRASOUND | OUTCOMES | Risk Assessment | Humans | Middle Aged | Risk Factors | Male | Forecasting | Angioplasty, Balloon, Coronary | Drug-Eluting Stents - adverse effects | Coronary Angiography | Coronary Artery Disease - complications | Female | Registries | Aged | Coronary Thrombosis - etiology | Heart attacks | Angina pectoris | Stents | Coronary vessels
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Coronary stents: Current status
by Garg, Scot and Serruys, Patrick W
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2010, Volume 56, Issue 10, pp. S1 - S42
Coronary artery stents revolutionized the practice of interventional cardiology after they were first introduced in the mid-1980s. Since then, there have been... 
clopidogrel | cost-effectiveness | restenosis | drug-eluting stents | sirolimus-eluting stents | stent fracture | myocardial infarction | bare-metal stents | paclitaxel-eluting stents | left main disease | saphenous vein grafts | stent thrombosis | zotarolimus-eluting stents | everolimus-eluting stents | diabetes | CARDIAC & CARDIOVASCULAR SYSTEMS | SIROLIMUS-ELUTING-STENT | RANDOMIZED CONTROLLED-TRIAL | ACUTE MYOCARDIAL-INFARCTION | INTRAVASCULAR ULTRASOUND PREDICTORS | SAPHENOUS-VEIN GRAFTS | OPTICAL COHERENCE TOMOGRAPHY | CLINICAL FOLLOW-UP | LONG-TERM SAFETY | CHRONIC TOTAL OCCLUSION | Coronary Vessels - pathology | Drug-Eluting Stents - trends | Angioplasty, Balloon, Coronary - instrumentation | Coronary Vessels - physiology | United States | Humans | Coronary Restenosis - prevention & control | Device Approval | Drug-Eluting Stents - adverse effects | Angioplasty, Balloon, Coronary - trends | Animals | Drug-Eluting Stents - standards | Stents - trends | Clinical Trials as Topic - methods | Angioplasty, Balloon, Coronary - standards | Stents - adverse effects | Stents - standards | Coronary Restenosis - etiology | Heart attacks | Angioplasty | Coronary vessels | Cardiovascular disease | Smooth muscle | Drug therapy | Stents | Thrombosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice the COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revascularization in Daily Practice)
by Smits, Pieter C and Vlachojannis, Georgios J and McFadden, Eugene Patrick and Royaards, Kees-Jan and Wassing, Jochem and Joesoef, Kaiyum Sheik and Van Mieghem, Carlos and Van De Ent, Martin
JACC: Cardiovascular Interventions, ISSN 1936-8798, 08/2015, Volume 8, Issue 9, pp. 1157 - 1165
Objectives This study sought to report the 5-year outcomes of everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES) in an all-comers population... 
coronary artery disease | drug-eluting stent | everolimus-eluting stent | paclitaxel-eluting stent | long-term follow-up | randomized trial | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | THROMBOSIS | BARE-METAL | LESIONS | RESPONSES | SPIRIT III | NEOATHEROSCLEROSIS | SYNTAX TRIAL | CLINICAL-OUTCOMES | ARTERY-DISEASE | Single-Blind Method | Prospective Studies | Percutaneous Coronary Intervention - mortality | Humans | Metals | Middle Aged | Male | Everolimus - administration & dosage | Prosthesis Design | Netherlands | Percutaneous Coronary Intervention - instrumentation | Time Factors | Female | Paclitaxel - administration & dosage | Myocardial Infarction - etiology | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Coronary Artery Disease - mortality | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Thrombosis - etiology | Percutaneous Coronary Intervention - adverse effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: Results from the PEPCAD China ISR trial
by Xu, Bo and Gao, Runlin and Wang, Jian'An and Yang, Yuejin and Chen, Shaoliang and Liu, Bin and Chen, Fang and Li, Zhanquan and Han, Yaling and Fu, Guosheng and Zhao, Yelin and Ge, Junbo and PEPCAD China ISR Trial and PEPCAD China ISR Trial Investigators
JACC: Cardiovascular Interventions, ISSN 1936-8798, 02/2014, Volume 7, Issue 2, pp. 204 - 211
Objectives The intention of the PEPCAD China ISR (A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated versus Paclitaxel-Eluting Stent for the... 
in-stent restenosis | paclitaxel-eluting stent(s) | paclitaxel-coated balloon(s) | CARDIAC & CARDIOVASCULAR SYSTEMS | ANGIOPLASTY | IMPLANTATION | FOLLOW-UP | CATHETER | Single-Blind Method | Recurrence | Angioplasty, Balloon, Coronary - instrumentation | Prospective Studies | Humans | Middle Aged | Male | Prosthesis Design | Angioplasty, Balloon, Coronary - adverse effects | Coronary Restenosis - diagnosis | Angioplasty, Balloon, Coronary - mortality | Time Factors | China | Coronary Restenosis - mortality | Female | Paclitaxel - administration & dosage | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Coated Materials, Biocompatible | Coronary Restenosis - therapy | Vascular Access Devices | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Impact of Post-Intervention Minimal Stent Area on 9-Month Follow-Up Patency of Paclitaxel-Eluting Stents. An Integrated Intravascular Ultrasound Analysis From the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials
by Doi, Hiroshi and Maehara, Akiko and Mintz, Gary S and Yu, Alan and Wang, Hong and Mandinov, Lazar and Popma, Jeffrey J and Ellis, Stephen G and Grube, Eberhard and Dawkins, Keith D and Weissman, Neil J and Turco, Mark A and Ormiston, John A and Stone, Gregg W
JACC: Cardiovascular Interventions, ISSN 1936-8798, 12/2009, Volume 2, Issue 12, pp. 1269 - 1275
Objectives: We investigated the predictive value of the intravascular ultrasound (IVUS) measured post-intervention minimum stent area (MSA) on 9-month... 
intravascular ultrasound | paclitaxel-eluting stent | in-stent restenosis | stent expansion | COMPLEX | CARDIAC & CARDIOVASCULAR SYSTEMS | IMPLANTATION | RESTENOSIS | CORONARY-ARTERY-DISEASE | SIROLIMUS | Predictive Value of Tests | Angioplasty, Balloon, Coronary - instrumentation | Prospective Studies | Humans | Metals | Middle Aged | Ultrasonography, Interventional | Male | Prosthesis Design | Thrombosis - diagnostic imaging | Angioplasty, Balloon, Coronary - adverse effects | Coronary Artery Disease - physiopathology | Time Factors | Female | Odds Ratio | Paclitaxel - administration & dosage | Stents | Coronary Restenosis - etiology | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Thrombosis - physiopathology | Double-Blind Method | Risk Assessment | Risk Factors | Logistic Models | Treatment Outcome | Clinical Trials as Topic | Coronary Restenosis - diagnostic imaging | Coronary Angiography | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Thrombosis - etiology | ROC Curve | Aged | Coronary Restenosis - physiopathology | Vascular Patency
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease: Twelve-Month Zilver PTX Randomized Study Results
by Dake, Michael D and Ansel, Gary M and Jaff, Michael R and Ohki, Takao and Saxon, Richard R and Smouse, H Bob and Zeller, Thomas and Roubin, Gary S and Burket, Mark W and Khatib, Yazan and Snyder, Scott A and Ragheb, Anthony O and White, J King and Machan, Lindsay S and Zilver PTX Investigators
Circulation: Cardiovascular Interventions, ISSN 1941-7640, 10/2011, Volume 4, Issue 5, pp. 495 - 504
BACKGROUND—Sustained benefits of drug-eluting stents in femoropopliteal arteries have not been demonstrated. This prospective, multinational, randomized study... 
Peripheral vascular disease | Paclitaxel-eluting stent | Angioplasty | Drug-eluting stent | CARDIAC & CARDIOVASCULAR SYSTEMS | drug-eluting stent | paclitaxel-eluting stent | PERFORMANCE | peripheral vascular disease | LESIONS | PLACEMENT | INHIBITION | IMPLANTATION | SUPERFICIAL FEMORAL-ARTERY | CLINICAL-TRIALS | RESTENOSIS | FRACTURES | NITINOL STENTS | angioplasty | Femoral Artery - pathology | Prospective Studies | Follow-Up Studies | Peripheral Arterial Disease - pathology | Humans | Middle Aged | Paclitaxel - adverse effects | Male | Treatment Outcome | Popliteal Artery - metabolism | Peripheral Arterial Disease - therapy | Disease-Free Survival | Peripheral Arterial Disease - physiopathology | Femoral Artery - metabolism | Female | Aged | Popliteal Artery - pathology | Angioplasty, Balloon | Drug-Eluting Stents - utilization | Paclitaxel - administration & dosage | Blood Vessel Prosthesis Implantation | Vascular Patency
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Coronary arterial remodeling and out-stent plaque change after drug-eluting stent implantation - Comparison between zotarolimus-eluting stents and paclitaxel-eluting stents
by Muraoka, Yoshitaka and Sonoda, Shinjo and Kashiyama, Kuninobu and Kamezaki, Fumihiko and Tsuda, Yuki and Araki, Masaru and Tamura, Masahito and Takeuchi, Masaaki and Abe, Haruhiko and Okazaki, Masahiro and Otsuji, Yutaka
Circulation Journal, ISSN 1346-9843, 2013, Volume 77, Issue 2, pp. 363 - 371
Background: Out-stent plaque characteristics and eosinophilic inflammatory response, which correlates with positive remodeling after first-generation... 
Out-stent plaque | Zotarolimuseluting stent | Paclitaxel-eluting stent | Intravascular ultrasound | Drug-eluting stent | CARDIAC & CARDIOVASCULAR SYSTEMS | NEOINTIMAL COVERAGE | OPTICAL COHERENCE TOMOGRAPHY | THROMBOSIS | Zotarolimus-eluting stent | RANDOMIZED CONTROLLED-TRIAL | BACKSCATTER INTRAVASCULAR ULTRASOUND | TISSUE CHARACTERIZATION | ENDEAVOR-III | BARE-METAL STENT | CLINICAL-PRACTICE | SIROLIMUS | Eosinophils - drug effects | Follow-Up Studies | Vasculitis - epidemiology | Humans | Middle Aged | Ultrasonography, Interventional | Male | Aged, 80 and over | Tubulin Modulators - administration & dosage | Female | Paclitaxel - administration & dosage | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Angioplasty, Balloon, Coronary - methods | Risk Factors | Coronary Restenosis - prevention & control | Treatment Outcome | Sirolimus - administration & dosage | Coronary Artery Disease - diagnostic imaging | Coronary Restenosis - epidemiology | Coronary Artery Disease - therapy | Vasculitis - drug therapy | Aged | Coronary Artery Disease - epidemiology | Eosinophils - cytology | Ventricular Remodeling - drug effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: An analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (TaxusStent Evaluated at Rotterdam Cardiology Hospital) registries
by Simsek, Cihan and Magro, Michael and Boersma, Eric and Onuma, Yoshinobu and Nauta, Sjoerd and Gaspersz, Marcia and Giessen, Wim and Domburg, Ron and Serruys, Patrick and Interventional Cardiologists Thora and Interventional Cardiologists of the Thoraxcenter
JACC: Cardiovascular Interventions, ISSN 1936-8798, 10/2010, Volume 3, Issue 10, pp. 1051 - 1058
textabstractObjectives The aim of this study was to assess the 6-year clinical outcome after unrestricted use of sirolimus-eluting stents (SES) or... 
restenosis | major clinical study | heart infarction | sirolimus-eluting stent(s) | follow up | percutaneous coronary intervention | stent thrombosis | drug use | target vessel revascularization | outcome assessment | priority journal | female | human | clinical trial | paclitaxel | bare-metal stent(s) | revascularization | in-stent restenosis | treatment outcome | article | cardiology | drug eluting stent | implantation | controlled study | paclitaxel-eluting stent(s) | mortality | bare metal stent | adult | male | intermethod comparison | rapamycin | register | INTRAVASCULAR ULTRASOUND ANALYSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | THROMBOSIS | TRIAL | SUBACUTE STENT | REAL-WORLD | IMPLANTATION | LARGE 2-INSTITUTIONAL COHORT | POOLED ANALYSIS | CORONARY-ARTERY-DISEASE | Angioplasty, Balloon, Coronary - instrumentation | Humans | Metals | Middle Aged | Male | Prosthesis Design | Angioplasty, Balloon, Coronary - adverse effects | Netherlands | Angioplasty, Balloon, Coronary - mortality | Time Factors | Female | Registries | Paclitaxel - administration & dosage | Myocardial Infarction - etiology | Stents | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Coronary Artery Disease - mortality | Chi-Square Distribution | Sirolimus - administration & dosage | Coronary Artery Disease - therapy | Thrombosis - etiology | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text The Everolimus-Eluting Stent in Real-World Patients. 6-Month Follow-Up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) Registry
by Onuma, Yoshinobu and Kukreja, Neville and Piazza, Nicolo and Eindhoven, Jannet and Girasis, Chrysafios and Schenkeveld, Lisanne and van Domburg, Ron and Serruys, Patrick W and Interventional Cardiologists Thora and Interventional Cardiologists of the Thoraxcenter (2000 to 2007)
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2009, Volume 54, Issue 3, pp. 269 - 276
Objectives: The purpose of this study was to investigate the impact of everolimus-eluting stents (EES) in comparison with bare-metal stents (BMS),... 
sirolimus-eluting stent | everolimus-eluting stent | paclitaxel-eluting stent | all-comer registry | CARDIAC & CARDIOVASCULAR SYSTEMS | IMPLANTATION | THROMBOSIS | COVERAGE | BARE-METAL | CORONARY-ARTERY-DISEASE | SIROLIMUS | Multivariate Analysis | Confidence Intervals | Prospective Studies | Humans | Immunosuppressive Agents - therapeutic use | Male | Case-Control Studies | Netherlands | Time Factors | Coronary Restenosis - mortality | Female | Registries | Surveys and Questionnaires | Odds Ratio | Paclitaxel - administration & dosage | Everolimus | Immunosuppressive Agents - administration & dosage | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Coronary Artery Disease - drug therapy | Coronary Artery Disease - mortality | Coronary Restenosis - drug therapy | Paclitaxel - therapeutic use | Coronary Restenosis - therapy | Regression Analysis | Sirolimus - administration & dosage | Survival Analysis | Heart attacks | Cardiology | Stents | Mortality | Coronary vessels
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Two‐year results and subgroup analyses of the PEPCAD China in‐stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug‐eluting stent in‐stent restenosis
by Xu, Bo and Qian, Jie and Ge, Junbo and Wang, Jian'an and Chen, Fang and Chen, Jiyan and Wei, Meng and Chen, Yundai and Yang, Yuejin and Gao, Runlin and PEPCAD China ISR Investigators and PEPCAD China ISR investigators
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 03/2016, Volume 87, Issue S1, pp. 624 - 629
Background The PEPCAD China ISR trial investigated the safety and efficacy of paclitaxel‐coated balloon (PCB) angioplasty in an Asian patient population with... 
drug‐eluting stent | in‐stent restenosis | paclitaxel‐eluting stents | paclitaxel‐coated balloon | drug-eluting stent | paclitaxel-eluting stents | in-stent restenosis | paclitaxel-coated balloon | CARDIAC & CARDIOVASCULAR SYSTEMS | ANGIOPLASTY | CATHETER | Single-Blind Method | Angioplasty, Balloon, Coronary - instrumentation | Prospective Studies | Percutaneous Coronary Intervention - mortality | Humans | Prosthesis Design | Angioplasty, Balloon, Coronary - adverse effects | Percutaneous Coronary Intervention - instrumentation | Angioplasty, Balloon, Coronary - mortality | Time Factors | China | Coronary Restenosis - mortality | Paclitaxel - administration & dosage | Myocardial Infarction - etiology | Coronary Restenosis - etiology | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Risk Factors | Treatment Outcome | Cardiac Catheters | Coated Materials, Biocompatible | Coronary Artery Disease - mortality | Coronary Restenosis - diagnostic imaging | Coronary Restenosis - therapy | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Percutaneous Coronary Intervention - adverse effects | Clinical trials | Drug therapy | Analysis | Cardiac patients | Stent (Surgery)
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: A randomized, single-centre, pilot study
by Beijk, Marcel A.M and Klomp, Margo and Verouden, Niels J.W and Van Geloven, Nan and Koch, Karel T and Henriques, José P.S and Baan, Jan and Vis, Marije M and Scheunhage, Esther and Piek, Jan J and Tijssen, Jan G.P and De Winter, Robbert J
European Heart Journal, ISSN 0195-668X, 05/2010, Volume 31, Issue 9, pp. 1055 - 1064
The purpose of this study was to evaluate the Genous(TM) endothelial progenitor cell capturing stent vs. the Taxus Liberte paclitaxel-eluting stent in patients... 
Restenosis | Percutaneous coronary intervention | Taxus | Stent | Genous | NUMBER | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOSIS | PACLITAXEL-ELUTING STENTS | ANTIBODY | 2-YEAR FOLLOW-UP | SLOW-RELEASE | THERAPY | INCREASE | INFLAMMATION | ARTERY-DISEASE | Single-Blind Method | Drug-Eluting Stents | Endothelial Cells | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Coronary Restenosis - prevention & control | Male | Treatment Outcome | Stem Cells | Pilot Projects | Graft Occlusion, Vascular - etiology | Tubulin Modulators - administration & dosage | Female | Aged | Paclitaxel - administration & dosage | Endothelium, Vascular | Clinical Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Clinical impact of second-generation everolimus-eluting stent compared with first-generation drug-eluting stents in diabetes mellitus patients: Insights from a nationwide coronary intervention register
by Kedhi, Elvin and Gomes, Marc E and Lagerqvist, Bo and Smith, J. Gustav and Omerovic, Elmir and James, Stefan and Harnek, Jan and Olivecrona, Göran K and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala kliniska forskningscentrum (UCR)
JACC: Cardiovascular Interventions, ISSN 1936-8798, 11/2012, Volume 5, Issue 11, pp. 1141 - 1149
Objectives: This study sought to study the second-generation everolimus-eluting stent (EES) as compared with first-generation sirolimus-eluting (SES) and... 
restenosis | SCAAR | sirolimus-eluting stent | everolimus-eluting stent | paclitaxel-eluting stent | stent thrombosis | all-cause mortality | condensed abstract | diabetes mellitus | SWEDEN | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOSIS | BARE-METAL STENTS | PACLITAXEL | SPIRIT IV | IMPLANTATION | OUTCOMES | ARTERY-DISEASE | Diabetic Angiopathies - surgery | Coronary Artery Disease - surgery | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Humans | Male | Prosthesis Design | Sirolimus - administration & dosage | Sweden | Female | Registries | Aged | Retrospective Studies | Paclitaxel - administration & dosage | Everolimus | Immunosuppressive Agents - administration & dosage | Percutaneous Coronary Intervention | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents
by Nakazawa, Gaku, MD and Finn, Aloke V., MD and Vorpahl, Marc, MD and Ladich, Elena R., MD and Kolodgie, Frank D., PhD and Virmani, Renu, MD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 57, Issue 4, pp. 390 - 398
Objectives The purpose of this study was to assess the mechanism(s) of late stent thrombosis (LST) and vascular healing responses in first-generation polymeric... 
Cardiovascular | Internal Medicine | drug-eluting stent | pathology | malapposition | vascular response | stent thrombosis | late stent thrombosis | SES | bare-metal stent(s) | DES | paclitaxel-eluting stent(s) | sirolimus-eluting stent(s) | BMS | LST | drug-eluting stent(s) | PES | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | BARE-METAL | FOLLOW-UP | IMPLANTATION | DEGRADATION-PRODUCTS | APPOSITION | RESTENOSIS | INTRAVASCULAR ULTRASOUND | ASSOCIATION | INSIGHTS | Angioplasty, Balloon, Coronary - instrumentation | Paclitaxel - pharmacology | Humans | Middle Aged | Male | Drug-Eluting Stents - adverse effects | Coronary Thrombosis - diagnostic imaging | Prosthesis Failure | Time Factors | Coronary Restenosis - mortality | Adult | Female | Registries | Coronary Restenosis - etiology | Coronary Stenosis - diagnostic imaging | Coronary Thrombosis - mortality | Coronary Stenosis - therapy | Risk Assessment | Angioplasty, Balloon, Coronary - methods | Coronary Restenosis - diagnostic imaging | Sirolimus - pharmacology | Radiography | Survival Analysis | Aged | Coronary Thrombosis - etiology | Medical colleges | Rapamycin | Thrombosis | Stent (Surgery) | Blood clot | Paclitaxel | Angina pectoris | Stents | Patients
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text 3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions. The SPIRIT II Trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions)
by Garg, Scot and Serruys, Patrick and Onuma, Yoshinobu and Dorange, Cécile and Veldhof, Susan and Miquel-Hébert, Karine and Sudhir, Krishnankutty and Boland, Jean and Huber, Kurt and Garcia, Eulogio and te Riele, Jan A.M and SPIRIT Investigators and SPIRIT II Investigators
JACC: Cardiovascular Interventions, ISSN 1936-8798, 12/2009, Volume 2, Issue 12, pp. 1190 - 1198
Objectives: This paper reports the 3-year clinical outcomes of the XIENCE V (Abbott Vascular, Santa Clara, California) everolimus-eluting stent (EES) compared... 
everolimus-eluting stent | paclitaxel-eluting stent | angioplasty | FUTURE-I | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | THROMBOSIS | 1ST HUMAN-EXPERIENCE | RANDOMIZED-TRIAL | Single-Blind Method | Angioplasty, Balloon, Coronary - instrumentation | Prospective Studies | United States | Humans | Middle Aged | Male | Prosthesis Design | Angioplasty, Balloon, Coronary - adverse effects | Angioplasty, Balloon, Coronary - mortality | Time Factors | Female | Paclitaxel - administration & dosage | Everolimus | Myocardial Infarction - etiology | Coronary Restenosis - etiology | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Risk Assessment | Europe | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Coronary Artery Disease - mortality | Coronary Angiography | Sirolimus - administration & dosage | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Thrombosis - etiology | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis) : Angiographic Results and 1-Year Clinical Outcomes
by Verheye, Stefan and Vrolix, Mathias and Kumsars, Indulis and Erglis, Anejs and Sondore, Dace and Agostoni, Pierfrancesco and Cornelis, Kristoff and Janssens, Luc P F and Maeng, Michael and Slagboom, Ton and Amoroso, Giovanni and Jensen, Lisette Okkels and Granada, Juan F and Stella, Pieter
JACC. Cardiovascular Interventions, ISSN 1936-8798, 10/2017, Volume 10, Issue 20, pp. 2029 - 2037
Objectives The aim of this first-in-human study was to assess the safety and effectiveness of the Virtue sirolimus-eluting balloon in a cohort of patients with... 
drug-eluting balloon | in-stent restenosis | Cardiology and Cardiovascular Medicine | extended release | sirolimus nanoparticle | Journal Article | porous angioplasty balloon | DRUG | CARDIAC & CARDIOVASCULAR SYSTEMS | PACLITAXEL-ELUTING STENTS | RANDOMIZED-TRIAL | BARE-METAL | COATED BALLOONS | DELIVERY | INHIBITION | CATHETER | ARTERY-DISEASE | Predictive Value of Tests | Angioplasty, Balloon, Coronary - instrumentation | Prospective Studies | Humans | Middle Aged | Male | Equipment Design | Feasibility Studies | Angioplasty, Balloon, Coronary - adverse effects | Percutaneous Coronary Intervention - instrumentation | Time Factors | Female | Stents | Sirolimus - adverse effects | Coronary Restenosis - etiology | Cardiovascular Agents - administration & dosage | Europe | Treatment Outcome | Cardiac Catheters | Coated Materials, Biocompatible | Coronary Restenosis - diagnostic imaging | Coronary Restenosis - therapy | Coronary Angiography | Sirolimus - administration & dosage | Intention to Treat Analysis | Aged | Cardiovascular Agents - adverse effects | Percutaneous Coronary Intervention - adverse effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Impact of stent platform of paclitaxel-eluting stents - Assessment of neointimal distribution on optical coherence tomography
by Otake, Hiromasa and Shite, Junya and Shinke, Toshiro and Miyoshi, Naoki and Kozuki, Amane and Kawamori, Hiroyuki and Nakagawa, Masayuki and Nagoshi, Ryoji and Hariki, Hirotoshi and Inoue, Takumi and Osue, Tsuyoshi and Taniguchi, Yu and Hiranuma, Noritoshi and Nishio, Ryo and Kinutani, Hiroto and Hirata, Ken-Ichi
Circulation Journal, ISSN 1346-9843, 2012, Volume 76, Issue 8, pp. 1880 - 1888
Background: The Taxus Express (TM) paclitaxel-eluting stent (Express-PES) and Taxus Liberte (TM) PES (Liberte-PES) have identical drugs, drug doses, and... 
Stent design | Thin struts | Optical coherence tomography | Paclitaxel-eluting stents | CARDIAC & CARDIOVASCULAR SYSTEMS | STRUT THICKNESS | COVERAGE | PORCINE CORONARY-ARTERIES | THROMBUS | PLAQUE | LESIONS | TRIAL | IMPLANTATION | RESTENOSIS | Drug-Eluting Stents | Paclitaxel - pharmacology | Follow-Up Studies | Tubulin Modulators - pharmacology | Humans | Middle Aged | Male | Prosthesis Design | Tomography, Optical Coherence - methods | Neointima - pathology | Aged, 80 and over | Female | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study
by Beijk, Marcel A. M and Klomp, Margo and van Geloven, Nan and Koch, Karel T and Henriques, José P. S and Baan, Jan and Vis, Marije M and Tijssen, Jan G. P and Piek, Jan J and de Winter, Robbert J
Catheterization and cardiovascular interventions, ISSN 1522-1946, 2011, Volume 78, Issue 2, pp. 189 - 195
In the prospective randomized TRIAS pilot study, the bio-engineered Genous™ endothelial progenitor cell capturing stent was compared with the Taxus Liberté™ SR... 
taxus | percutaneous coronary intervention | restenosis | genous | MULTICENTER | COMPLEX | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | PACLITAXEL-ELUTING STENTS | TRIAL | OUTCOMES | REGISTRY | LONG | Single-Blind Method | Angioplasty, Balloon, Coronary - instrumentation | Prospective Studies | Humans | Middle Aged | Male | Prosthesis Design | Angioplasty, Balloon, Coronary - adverse effects | Netherlands | Angioplasty, Balloon, Coronary - mortality | Time Factors | Myocardial Infarction - pathology | Coronary Artery Disease - pathology | Female | Thrombosis - prevention & control | Drug Therapy, Combination | Paclitaxel - administration & dosage | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Stents | Coronary Restenosis - etiology | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Coronary Restenosis - prevention & control | Treatment Outcome | Coronary Artery Disease - mortality | Coronary Restenosis - pathology | Thrombosis - pathology | Pilot Projects | Coronary Artery Disease - therapy | Thrombosis - etiology | Stem Cells - pathology | Aged | Myocardial Infarction - prevention & control | Endothelial Cells - pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights